BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/28/2025 3:10:35 AM | Browse: 6 | Download: 21
 |
Received |
|
2025-08-20 04:55 |
|
Peer-Review Started |
|
2025-08-20 04:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-09-28 10:48 |
|
Revised |
|
2025-10-02 16:09 |
|
Second Decision |
|
2025-10-23 02:33 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-10-23 05:00 |
|
Articles in Press |
|
2025-10-23 05:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-21 01:30 |
|
Publish the Manuscript Online |
|
2025-11-28 03:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Prudence is never excessive: Caution warranted in 5-aminosalicylic acid derivatives withdrawal for ulcerative colitis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Antonietta Gerarda Gravina, Raffaele Pellegrino and Alessandro Federico |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Raffaele Pellegrino, MD, Division of Hepatogastroenterology, Department of Precision Medicine,, University of Campania Luigi Vanvitelli, Via L. de Crecchio, Naples 80138, Italy. raffaele.pellegrino@unicampania.it |
| Key Words |
Exit strategy; Withdrawal; 5-aminosalicylic acid derivatives; Inflammatory bowel disease; Ulcerative colitis |
| Core Tip |
The discontinuation of 5-aminosalicylates in ulcerative colitis should be considered only in highly selected, low-risk patients. Notwithstanding this requirement, however, the evidence generated to date does not yet permit the formulation of a robust and definitive operational pathway. Strict monitoring and adherence to European Crohn’s and Colitis Organisation guidelines remain essential to balance the potential benefits against the risks of relapse and colorectal cancer. |
| Publish Date |
2025-11-28 03:10 |
| Citation |
<p>Gravina AG, Pellegrino R, Federico A. Prudence is never excessive: Caution warranted in 5-aminosalicylic acid derivatives withdrawal for ulcerative colitis. <i>World J Gastroenterol</i> 2025; 31(44): 113253</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i44/113253.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i44.113253 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
